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Objective:We sought to elucidate the risks for access site-related complications (ASCs) after percutaneous lower extremity
revascularization and to evaluate the beneﬁt of routine ultrasound-guided access (RUS) in decreasing ASCs.
Methods: We reviewed all consecutive percutaneous revascularizations (percutaneous transluminal angioplasty or stent)
performed for lower extremity atherosclerosis at our institution from 2002 to 2012. RUS began in September 2007.
Primary outcome was any ASC (bleeding, groin or retroperitoneal hematoma, vessel rupture, or thrombosis). Multi-
variable logistic regression was used to determine predictors of ASC.
Results: A total of 1371 punctures were performed on 877 patients (43% women; median age, 69 [interquartile range, 60-
78] years) for claudication (29%), critical limb ischemia (59%), or bypass graft stenosis (12%) with 4F to 8F sheaths. There
were 72 ASCs (5%): 52 instances of bleeding or groin hematoma, nine pseudoaneurysms, eight retroperitoneal hema-
tomas, two artery lacerations, and one thrombosis. ASCs were less frequent when RUS was used (4% vs 7%; P [ .02).
Multivariable predictors of ASC were age >75 years (odds ratio [OR], 2.0; 95% conﬁdence interval [CI], 1.1-3.7; P [
.03), congestive heart failure (OR, 1.9; 95% CI, 1.1-1.3; P[ .02), preoperative warfarin use (OR, 2.0; 95% CI, 1.1-3.5;
P[ .02), and RUS (OR, 0.4; 95% CI, 0.2-0.7; P < .01). Vascular closure devices (VCDs) were not associated with lower
rates of ASCs (OR, 1.1; 95% CI, 0.6-1.9; P[ .79). RUS lowered ASCs in those >75 years (5% vs 12%; P < .01) but not in
those taking warfarin preoperatively (10% vs 13%; P [ .47). RUS did not decrease VCD failure (6% vs 4%; P [ .79).
Conclusions:We were able to decrease the rate of ASCs during lower extremity revascularization with the implementation
of RUS. VCDs did not affect ASCs. Particular care should be taken with patients >75 years old, those with congestive
heart failure, and those taking warfarin. (J Vasc Surg 2015;61:405-12.)Vascular access site-related complications (ASCs) are a
major cause of perioperative morbidity and mortality
among patients undergoing percutaneous endovascular
intervention. ASCs occur at a rate of 1% to 9% in contem-
porary series of coronary angiography and intervention1,2;
the effects of ASCs include not only prolonged hospital
stay, patient discomfort, and higher health care costs
but also increased mortality rates even 1 year after the
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://dx.doi.org/10.1016/j.jvs.2014.07.099Although they are well described in the interventional
cardiology literature, the data on the incidence of and
risk factors for ASCs among patients undergoing lower ex-
tremity revascularization are relatively sparse. Relative to
patients with coronary artery disease, patients with periph-
eral vascular disease may be more likely to have atheroscle-
rosis affecting the common femoral artery. Vascular
surgeons in our division routinely use ultrasound for all
percutaneous procedures to improve our ability to access
the intended artery in the best location. Thus, the objec-
tives of this study were to describe the prevalence and pre-
dictors of ASCs in patients undergoing percutaneous lower
extremity revascularization and to evaluate the potential
beneﬁt of routine ultrasound-guided access (RUS) in
decreasing the rate of ASCs and potentially improving
the technical success of vascular closure devices (VCDs).
METHODS
Subjects and settings. The Beth Israel Deaconess
Medical Center Institutional Review Board approved this
study. Consent of the patient was not required because
this was a retrospective chart review that did not involve
use of any patient identiﬁers. We performed a retrospective
chart review of all consecutive patients undergoing lower
extremity percutaneous revascularization procedures from405
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ﬁed by Current Procedural Terminology codes for angio-
plasty or atherectomy, with or without stenting of the
lower extremities, including the iliac arteries. Indications
for intervention included intermittent claudication, critical
limb ischemia (rest pain or tissue loss), and stenosis or
impending graft failure of an existing bypass graft as docu-
mented on surveillance duplex imaging. Procedures per-
formed for acute limb ischemia or for reasons other than
peripheral arterial occlusive disease (eg, trauma, aneurysms)
were excluded. Only cases using common femoral artery ac-
cess were included. Procedures were performed through 4F
to 8F sheaths, preferentially through retrograde contralat-
eral and occasionally anterograde ipsilateral access. RUS,
deﬁned as universal usage in all consecutive patients, was
instituted by the vascular surgeons at our institution in
September 2007. Before this period, ultrasound-guided
access was used infrequently and only selectively. Arterial
closure was either by direct manual compression or through
the use of a VCD (we use most frequently the Perclose
ProGlide; Abbott Laboratories, Redwood City, Calif).
Unless it was contraindicated, patients who were taking
warfarin preoperatively were instructed to discontinue it
5 days before their procedure for elective procedures. The
international normalized ratio (INR) was not routinely
measured preoperatively and therefore is not reported here.
Intraoperatively, patients were heparinized with 80 to 100
units per kilogram, and activated clotting times were typi-
cally maintained >250 seconds for iliofemoral and
>300 seconds for tibial interventions. Postoperatively, pa-
tients were typically given a loading dose of clopidogrel
300 mg and then maintained with clopidogrel 75 mg/day
for 30 days and aspirin 325 mg/day indeﬁnitely thereafter.
Clopidogrel was not typically loaded preoperatively as the
patients who are not intervened on percutaneously often
undergo surgical bypass shortly thereafter.
Measurements and outcomes. We identiﬁed the
following types of ASCs: bleeding or groin hematomas
that required transfusion, led to hemodynamic instability,
or caused an increased length of stay; pseudoaneurysm
(diagnosed by ultrasound); retroperitoneal hematoma
(diagnosed by computed tomography); artery laceration
or rupture (diagnosed intraoperatively); and thrombosis.
Procedural success was deﬁned as residual stenosis <30%
as assessed on single-view completion angiography. Pro-
cedures were deﬁned as multilevel if lesions in more than
one vascular bed (eg, aortoiliac, femoropopliteal, tibial)
were intervened on. VCD failure was deﬁned as inadequate
hemostasis, failure of the device to deploy, or occlusion of
the common femoral artery after deployment. Academic
year was divided into two halves: the ﬁrst half from July
through December, and the second from January through
June. Information on postdischarge mortality was obtained
by the Social Security Death Index.
Ultrasound technique. At our institution, nearly all
punctures are performed by the vascular surgery fellows
(and occasionally general surgery residents under supervision
of the fellow). Each July, the junior fellow is taught thefollowing technique by his or her senior fellow: After sterile
draping, the ultrasound probe is used to visualize the com-
mon femoral artery. The femoral bifurcation is ﬁrst identiﬁed
with a transverse view.With the bifurcation kept in focus, the
view is switched to longitudinal, and the femoral bifurcation
and femoral head are identiﬁed, giving a clear view of the
common femoral artery. The probe is maintained in a posi-
tion parallel with the table, which requires substantial pres-
sure in an obese groin. This avoids the misperception of an
external iliac artery appearing to be a ﬂat common femoral
artery over the femoral head. Keeping the bifurcation at
the inferior edge of the screen also aids in avoiding a high
puncture. Care is taken to identify a segment of common
femoral artery with a minimum of plaque and calciﬁcation
not only on the anterior wall but also on the posterior wall
as well, which could interfere with the function of the Pro-
Glide closure device. A nick in the skin is made with a No.
11 blade, and the subcutaneous tissue along the course of
the wire is spread with a straight snap under ultrasound sur-
veillance. This creates a track for the suture-mediated closure
device to freely pass down to the artery at completion of the
procedure. A micropuncture needle is then inserted under
ultrasound guidance, with care taken to see the entire length
of the needle as well as the length of the common femoral
artery ﬁlling the ultrasound screenwith the long view. (Note:
during the earlier years of the study [2002-2004], 19-gauge
needles were often used rather than micropuncture needles.)
This maneuver has a learning curve but ensures an anterior
wall puncture. Aftermicropuncture needle access and 0.018-
inchwire passage, the ultrasound image demonstrating this is
stored, and ﬂuoroscopy is used to conﬁrm puncture over the
femoral head.We think that ultrasound alone cannot exclude
a high puncture. If ﬂuoroscopy demonstrates puncture
above the femoral head, the needle is removed and reinserted
lower, with care taken to ensure that the femoral bifurcation
is seen together with the needle.
Statistical analysis. All analyses were performed on a
per-puncture and intention-to-treat basis. Thus, if an
attempt at closure was made with a VCD, the puncture was
categorized as such, even if the VCD failed and hemostasis
was ultimately achieved by manual compression. Patient
demographics and outcomes were reported as absolute
numbers and percentages. Pearson c2 and Fisher exact test
were used for comparisons of categorical variables. Means
of continuous variables were compared with the Student
t-test, assuming equal variances, whereas medians of
continuous variables were compared with the Wilcoxon
rank sum test. Multivariable logistic regression modeling
was used to identify independent predictors of access site
complications. Statistical signiﬁcance was deﬁned as a P
value < .05. All statistical analyses were performed with
Stata 12.0 (StataCorp, College Station, Tex).
RESULTS
Patient characteristics. During the study period, there
were a total of 925 patients who underwent 1356 proce-
dures, resulting in 1419 punctures. Forty-eight punctures
were excluded because of intentional nonecommon
Table I. Number and proportion of punctures obtained under ultrasound guidance over time
Year 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Total number of punctures 10 30 109 180 64 59 186 189 183 232 129
Number in which ultrasound was used 0 2 1 2 3 33 164 180 182 229 128
Percentage in which ultrasound was used 0.0 6.7 0.9 1.1 4.7 55.9 88.2 95.2 99.5 98.7 99.2
Table II. Comparison of demographics, baseline
comorbidities, and preoperative anticoagulant use
between patients who underwent routine ultrasound-
guided access (RUS) and those who did not
Non-RUS RUS
P
(n ¼ 447; 33%),
No. (%)
(n ¼ 924; 67%),
No. (%)
Age
<65 years 164 (34) 321 (35) .24
65-74 years 107 (24) 261 (28)
$75 years 176 (39) 342 (37)
Female 190 (42) 405 (44) .68
BMI
Underweight
(BMI <18.5)
26 (6) 36 (4) <.01
Normal weight
(BMI 18.5-24.9)
124 (28) 262 (28)
Overweight
(BMI 25-29.5)
107 (24) 301 (33)
Obese (BMI 30þ) 190 (42) 325 (35)
HTN 346 (80) 723 (78) .57
HPL 229 (53) 594 (64) <.01
DM 236 (54) 590 (64) <.01
CAD 212 (49) 406 (44) .09
Hx of MI 86 (20) 164 (18) .37
Aﬁb 59 (14) 130 (14) .87
Hx TIA 19 (4) 34 (4) .55
Hx CVA 59 (14) 98 (11) .12
CRI 60 (14) 164 (18) .07
ESRD on HD 31 (7) 100 (11) .04
CHF 96 (22) 160 (17) .04
COPD 47 (11) 93 (10) .70
Current smoker 85 (21) 162 (18) .25
Prior smoker 139 (38) 390 (45) .02
Preoperative
anticoagulants
Aspirin 225 (65) 644 (70) .06
Clopidogrel 128 (37) 345 (38) .80
Warfarin 61 (17) 145 (16) .67
Aﬁb, Atrial ﬁbrillation; BMI, body mass index; CAD, coronary artery dis-
ease; CHF, congestive heart failure; CRI, chronic renal insufﬁciency;
COPD, chronic obstructive pulmonary disorder; CVA, cerebrovascular ac-
cident; DM, diabetes mellitus; ESRD, end-stage renal disease; HD, hemo-
dialysis; HPL, hyperlipidemia; HTN, hypertension; Hx, history; MI,
myocardial infarction; TIA, transient ischemic attack.
JOURNAL OF VASCULAR SURGERY
Volume 61, Number 2 Lo et al 407femoral artery access; these included 36 brachial, nine
bypass graft, two superﬁcial femoral artery, and one axillary
artery access procedures. The study population thus
included 1371 punctures (43% women; mean age, 69 6
12 years). Indications for the procedure were claudication
in 29%, critical limb ischemia in 59%, and bypass graft
stenosis or failure in the remaining 12%. RUS was used for
924 punctures (67%). The proportion of punctures ob-
tained under ultrasound guidance increased over time
(Table I). Access closure was obtained by manual
compression in 49% of punctures and the use of VCDs in
47%. The method of closure was undocumented in the
remaining 4% of punctures. However, of note, >50% of
these were performed in the ﬁrst 4 years of the study,
suggesting that closure was more likely to have been by
manual compression. In univariate analysis, patients who
underwent RUS were less likely to be obese and to have
congestive heart failure (CHF) and more likely to have
hyperlipidemia and diabetes, to have a past smoking history,
and to be dialysis dependent (Table II).
ASCs occurred in 72 patients (5%): 52 instances of
bleeding or groin hematoma, nine pseudoaneurysms, eight
retroperitoneal hematomas, two artery lacerations, and one
thrombotic complication. Additional procedures were per-
formed for 22 complications; two complications were
recognized intraoperatively and immediately addressed,
whereas 11 patients returned to the operating room after
their complications were identiﬁed postoperatively. All
nine patients who developed pseudoaneurysms were
treated with ultrasound-guided thrombin injection. Fig 1
shows the rate of ASCs over time.
In general, demographics and baseline comorbidities
were similar between patients who developed ASCs and
those who did not (Table III). However, patients who
had ASCs were signiﬁcantly older (median age, 73 vs
69 years; P < .01), were more likely to have CHF (35%
vs 18%; P < .01), and were more likely to be taking
warfarin preoperatively (31% vs 15%; P < .01). Notable fac-
tors that did not have a signiﬁcant association with ASCs
were gender, body mass index (BMI), tobacco use, and
preoperative use of aspirin and clopidogrel.
Procedural characteristics. On univariate analysis,
there was no difference in ASC rates based on various pro-
cedural characteristics, such as retrograde vs anterograde
access, procedural success, multilevel intervention, or prot-
amine reversal (Table IV). Operator experience did not
appear to be associated with an excess of ASCs as rates
were similar between the ﬁrst and second halves of the
academic year (6% vs 5%). Procedure-related factors thatwere associated with lower rates of ASCs were the use of
ultrasound-guided access (4% vs 7%) and the use of VCDs
(4% vs 6%). Failure of the VCD occurred in 40 cases (6%),
of which six (15%) developed an ASC.
Results of our multivariable logistic regression model
indicated that independent predictors of ASCs were age
>75 years (odds ratio [OR], 2.0; 95% conﬁdence interval
[CI], 1.1-3.7), CHF (OR, 1.9; 95% CI, 1.1-3.5), and
Fig 1. Access site-related complication (ASC) rates by year of
study. The total number of procedures per period is indicated in
parentheses. Routine ultrasound-guided access (RUS) was initi-
ated in September of 2007.
Table III. Comparison of demographics, baseline
comorbidities, and preoperative anticoagulant use
between patients who developed an access site-related
complication (ASC) and those who did not
ASC No ASC
P
(n ¼ 72; 5%),
No. (%)
(n ¼ 1299; 95%),
No. (%)
Age
<65 years 15 (21) 470 (36) .01
65-74 years 20 (28) 348 (27)
$75 years 37 (51) 481 (37)
Female 36 (50) 559 (43) .27
BMI
Underweight
(BMI <18.5)
26 (6) 58 (5) .77
Normal weight
(BMI 18.5-24.9)
29 (28) 368 (31)
Overweight
(BMI 25-29.5)
17 (37) 384 (32)
Obese (BMI $30) 39 (29) 382 (32)
HTN 56 (78) 1013 (79) .88
HPL 37 (51) 786 (61) .11
DM 39 (34) 787 (61) .26
CAD 38 (53) 580 (45) .23
Hx of MI 15 (21) 235 (18) .64
Aﬁb 13 (18) 176 (14) .30
Hx TIA 3 (4) 50 (4) .76
Hx CVA 7 (10) 150 (12) .71
CRI 8 (11) 216 (17) .25
ESRD on HD 6 (8) 125 (10) .84
CHF 25 (35) 231 (18) <.01
COPD 4 (6) 136 (11) .23
Current smoker 16 (23) 231 (19) .43
Prior smoker 24 (37) 505 (44) .31
Preoperative
anticoagulants
Aspirin 53 (77) 816 (68) .18
Clopidogrel 28 (41) 445 (37) .61
Warfarin 22 (31) 184 (15) <.01
Aﬁb, Atrial ﬁbrillation; BMI, body mass index; CAD, coronary artery dis-
ease; CHF, congestive heart failure; CRI, chronic renal insufﬁciency;
COPD, chronic obstructive pulmonary disorder; CVA, cerebrovascular ac-
cident; DM, diabetes mellitus; ESRD, end-stage renal disease; HD, hemo-
dialysis; HPL, hyperlipidemia; HTN, hypertension; Hx, history; MI,
myocardial infarction; TIA, transient ischemic attack.
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(Table V). Routine ultrasound surveillance signiﬁcantly
decreased the odds of having an access complication
(OR, 0.4; 95% CI, 0.2-0.7), whereas VCDs did not (OR,
1.1; 95% CI, 0.6-1.9).
RUS. Differences in ASC rates between patients in
whom RUS was used and those in whom it was not were
analyzed among groups at particularly high risk (Table VI)
who had been identiﬁed on univariate analysis. RUS
appeared to be protective against ASCs for elderly patients
(5% vs 12%; P< .01) but not for those with CHF and those
taking warfarin preoperatively. In addition, RUS did not
appear to improve VCD failure rates (6% vs 4%; P ¼ .79).
When the speciﬁc types of ASCs were analyzed (Fig 2),
we found that the complication that had the greatest
reduction in incidence after RUS was pseudoaneurysm
development. Pseudoaneurysm occurrence was 86% lower
in patients in whom RUS was used. Retroperitoneal hema-
tomas and artery lacerations were both reduced by 52% and
bleeding and groin hematomas by 29%. There were no
thrombotic complications when RUS was used.
ASC rates before and after RUS for each BMI category
were calculated (Fig 3). Overall, patients who were under-
weight (BMI <18.5) had the highest ASC rates. Rates of
ASCs decreased for normal weight (9% vs 3%; P ¼ .01),
overweight (7% vs 6%; P ¼ .81), and obese patients (7%
vs 4%; P ¼ .09) in whom RUS was used but not for under-
weight patients.
DISCUSSION
In our series of femoral punctures for lower extremity
peripheral vascular intervention, ASCs occurred at a rate
of 5%. Independent predictors of ASCs were age, CHF,
and preoperative warfarin use. RUS more than halved the
odds for development of an ASC, but VCDs were not pro-
tective. Among high-risk groups, RUS was able to decrease
ASC rates for elderly patients but not for those taking
warfarin or with CHF. Finally, RUS did not improve
VCD failure rates.Advanced age ($75 years), CHF, and preoperative
warfarin use are risk factors that have been previously
described by other authors.1 Age and comorbidities such
as CHF are likely to be surrogate markers for more
advanced atherosclerotic disease and vessel calciﬁcation.
Although patients in our study were instructed to stop
warfarin preoperatively, it has been shown that the INR
in up to 7% of patients may not normalize even when
warfarin is held 6 days in advance of surgery.5 Furthermore,
even when the INR is conﬁrmed to have normalized, pa-
tients receiving chronic warfarin therapy still demonstrate
increased intraoperative blood loss and requirement for
postoperative transfusion.6
Procedural factors previously foundtopredict higher rates
of ASCs are antegrade vs retrograde approach,7 interventional
rather than diagnostic procedures,8-10 and procedural indica-
tion.11Diagnostic angiogramswerenot included inour study,
Table IV. Comparison of access site-related
complication (ASC) rates for various procedure-related
characteristics
No. (%) P
Indication
Claudication 15 (4) .16
Critical limb ischemia 45 (6)
Bypass graft failure/restenosis of native vessel 12 (7)
Ultrasound-guided access
Used 33 (4) .02
Not used 39 (7)
Access direction
Retrograde 59 (5) .13
Antegrade 13 (8)
Sheath size
<5F 3 (6) .06
5F 26 (4)
6F 39 (7)
>6F 4 (5)
Technical success
Achieved 71 (4) 1.00
Failed 1 (5)
Level
Single level 44 (5) .24
Multilevel 28 (6)
Closure
Manual compression 38 (6) .24
Vascular closure device 29 (4)
Unknown 5 (9)
Reversal with protamine
Used 5 (6) .80
Not used 67 (5)
Academic period
July-December 38 (6) .40
January-June 34 (5)
Table V. Multivariable predictors of access site-related
complications (ASCs)
OR 95% CI P
Age
<65 years d d d
65-74 years 1.4 0.7-3.0 .32
$75 years 2.0 1.1-3.7 .03
CHF 1.9 1.1-3.3 .02
Preoperative warfarin use 2.0 1.1-3.5 .02
VCD vs MC 1.1 0.6-1.9 .79
RUS 0.4 0.2-0.7 <.01
CHF, Congestive heart failure; CI, conﬁdence interval; MC, manual
compression; OR, odds ratio; RUS, routine ultrasound-guided access; VCD,
vascular closure device.
Table VI. Comparison of access site-related
complication (ASC) rates among high-risk groups in
whom routine ultrasound-guided access (RUS) was used
vs those in whom it was not
No RUS, % RUS, % P
Overall ASC rate 7 4 .02
ASC rate in elderly patients
($75 years)
12 5 <.01
ASC rate in patients with CHF 13 7 .13
ASC rate in patients taking
warfarin preoperatively
13 10 .47
VCD failure rate 4 6 .79
CHF, Congestive heart failure; VCD, vascular closure device.
Fig 2. Breakdown of types of access site-related complications
(ASCs) with and without routine ultrasound-guided access (RUS).
U/S, Ultrasound.
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ation exists. However, we did notice a general trend toward
higherASCrates amongpatientswithmore advancedor com-
plex disease. For example, although the differences were
nonsigniﬁcant, there were higher complication rates among
patients with critical limb ischemia vs those with claudication,
among procedures performed through an antegrade vs a
retrograde approach, among patients who had multilevel
vs single-level disease, and among procedures that weretechnically unsuccessful. All these variables appear to be prox-
ies for a heavier burden of disease.
After controlling for other relevant variables, we did
not ﬁnd VCDs to be associated with lower ASC rates.
Despite their widespread use and increasing popularity,12
VCDs have in fact never been conclusively shown to
decrease ASC rates relative to manual compression.13-16
Whereas they do reduce the time to hemostasis and
mobility of the patient, VCDs may in fact increase the
rate of vascular complications by ﬁvefold when they
fail.17,18 This certainly was the case in our study, in which
VCD failure was associated with a 15% ASC rate. RUS did
not appear to decrease VCD failure rates, but this is
perhaps because failure of suture-mediated devices is often
due to device mishandling or defect (suture breakage or su-
tures pulling through the arterial wall) in addition to vessel
Fig 3. Access site-related complication (ASC) rates by body mass index (BMI) category (a) in all patients, (b) in
patients in whom routine ultrasound-guided access (RUS) was not used, and (c) in patients in whom RUS was used.
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trial comparing the use of suture-mediated closure devices
vs manual compression for endovascular interventions per-
formed for peripheral vascular disease, Starnes et al re-
ported no association of calciﬁed plaque to vascular
access site or device complications. Interestingly, neither
of the two patients who developed major access site com-
plications in their study had evidence of calciﬁed plaque
in the femoral vessels.
Given that patient factors are rarely modiﬁable and
VCDs, despite their other beneﬁts, have not made a
demonstrable difference in vascular complication rates,
arguably the best target for reducing ASC rates is improving
femoral puncture technique. Indeed, data from our institu-
tion show that the most signiﬁcant multivariable predictor
for development of a vascular access-related complication
was whether routine ultrasound guidance was used for
puncture.
When external anatomic or ﬂuoroscopic landmarks are
used to guide access, the optimal location of femoral punc-
ture is missed in approximately 13% of patients undergoing
femoral access.22 Considering the association of retroperi-
toneal hematomas with high punctures23,24 and pseudoa-
neurysms with low punctures,25 it naturally follows that
the beneﬁt of using ultrasound guidance to identify the
optimal location for femoral arteriotomy would be most
evident in these two complications. Looking at individual
categories of ASCs, we conﬁrmed this to be the case aswe found that RUS had the greatest impact in decreasing
the development of retroperitoneal hematomas and
pseudoaneurysms.
With regard to BMI, RUS reduced ASC rates in pa-
tients of all BMI categories except those who were under-
weight, who in fact had the highest ASC rates overall.
Although not intuitive, this phenomenon has in fact been
previously described by multiple authors studying the asso-
ciation between BMI and outcomes after percutaneous
coronary interventions.1,26-29 This so-called obesity
paradox, in which the distribution of postoperative compli-
cations assumes a U shape, with the highest rates of com-
plications at the extremes of BMIs and the lowest rates
of complications occurring in obese patients, may be
explained by several potential factors. Patients with lower
BMI may have less intravascular reserve and therefore be
more prone to manifesting hemodynamic changes and
requiring blood transfusion. Similarly, patients with lower
BMIs may have commensurately lower creatinine clear-
ance, which can lead to higher relative concentrations of
antiplatelet and other anticoagulant medications (eg, clopi-
dogrel) that are not dosed on the basis of weight.
Ultrasound-guided access requires a certain amount of
tissue between the ultrasound probe and the target vessel
to best visualize the trajectory of the needle. Thus, thinner
patients may not have sufﬁcient space to derive beneﬁt
from ultrasound guidance. Perhaps for patients with low
BMI, our technique should be modiﬁed to simply localize
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femoral puncture by the standard Seldinger technique
with ﬂuoroscopic conﬁrmation.
Finally, underweight patients are more likely to have
smaller femoral vessels more prone to injury secondary to
arteriotomy and instrumentation. Indeed, women, who
have been shown to have common femoral arteries of
smaller diameter and shorter length than those of men,30
have also been consistently shown to have higher rates of
ASCs.1,2,31 In addition, BMI appears to be a more impor-
tant predictor of ASCs in women than in men.29 Of note,
we did not ﬁnd female gender to be associated with higher
ASC rates, but perhaps our study was underpowered to
detect a signiﬁcant difference.
Two multicenter randomized controlled trials have
attempted to elucidate the beneﬁt of ultrasound-guided
femoral puncture. In the Femoral Arterial Access with Ul-
trasound Trial (FAUST), Seto et al compared outcomes of
501 patients randomized to ﬂuoroscopically guided punc-
ture vs 503 patients randomized to ultrasound-guided
puncture.32 Procedures included coronary (91%) or periph-
eral (9%) diagnostic angiograms and percutaneous inter-
ventions. Ultrasound guidance was associated with fewer
attempts and reduced time for access, higher ﬁrst-pass
rates, and lower rate of accidental venipuncture. In addi-
tion, ultrasound guidance reduced the risk of vascular ac-
cess complications by 59% (1.4% vs 3.4%; P ¼ .041)
compared with ﬂuoroscopic guidance.
In a more recent trial, interventional radiologists from
two institutions randomized 208 patients undergoing
retrograde puncture of the common femoral artery to
either ultrasound-guided or palpation-guided puncture.33
As with the FAUST trial, higher ﬁrst-pass success rates,
fewer attempts required for access, and reduced times to
sheath insertion were seen in the group in whom
ultrasound-guided puncture was used. ASC rates were
also lower in the ultrasound group, but this difference
did not reach statistical signiﬁcance (4% vs 0%; P ¼
.052). Unfortunately, the procedures performed in this
study were done for a wide range of indications, including
peripheral artery disease, carotid artery stenosis, subarach-
noid hemorrhage, renal artery stenosis, and others, thereby
limiting the generalizability of the results.
Our study has several limitations. First, this was a
single-institution retrospective review. Thus, our results
are subject to selection and information bias. Our division
currently uses the Perclose ProGlide, but in the earlier years
of this study, several types of VCDs were used. In addition,
unlike ultrasound guidance, which was used routinely after
2007, VCDs were not used in all patients and were in fact
typically avoided in patients with extensive common
femoral artery calciﬁcation, depending on the surgeon’s
judgment and preference. Thus, the VCD failure rate
would likely have been higher without RUS. It is possible
that operator experience over time may be responsible for
some improvements associated with the institution of
RUS. However, fellows (and some residents under supervi-
sion of the fellow) perform nearly all punctures and thesenior fellow trains the junior fellow in July, which makes
this less likely. The switch to micropuncture needles in
2004 may have also contributed to some degree, and we
certainly use them because we do believe they may help
prevent ASCs, particularly in situations in which multiple
attempts or punctures are made. However, there was no
appreciable decrease in ASC rates that correlated with the
adoption of micropuncture needles, and only a minor pro-
portion of punctures were performed with 19-gauge nee-
dles. Finally, our study was not inclusive of diagnostic
angiograms, which are historically associated with fewer
vascular complications than interventional procedures,
given the typically smaller proﬁle and lack of anticoagula-
tion. It would be interesting to see if RUS would similarly
demonstrate a reduction in ASC rates in purely diagnostic
procedures. This would likely require a much larger cohort.
Regardless, we use RUS for diagnostic procedures as well.
CONCLUSIONS
Among patients undergoing percutaneous lower ex-
tremity revascularization, those at highest risk for develop-
ment of ASCs include patients of advanced age
($75 years), patients with CHF, and those taking warfarin
preoperatively. Routine ultrasound-guided puncture of the
femoral artery decreases the rate of vascular access compli-
cations by optimizing the site of arteriotomy. In contrast,
VCDs are not associated with fewer vascular complications
and in fact can lead to higher rates of hemorrhage and he-
matoma when they fail.
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